Interaction between a chromosome 10 RET enhancer and chromosome 21 in the Down syndrome–Hirschsprung disease association

S Arnold, A Pelet, J Amiel, S Borrego… - Human …, 2009 - Wiley Online Library
S Arnold, A Pelet, J Amiel, S Borrego, R Hofstra, P Tam, I Ceccherini, S Lyonnet, S Sherman
Human mutation, 2009Wiley Online Library
Individuals with Down syndrome (DS) display a 40‐fold greater risk of Hirschsprung disease
(HSCR) than the general population of newborns implicating chromosome 21 in HSCR
etiology. Here we demonstrate that the RET enhancer polymorphism RET+ 9.7 (rs2435357:
C> T) at chromosome 10q11. 2 is associated with HSCR in DS individuals both by
transmission disequilibrium (P= 0.0015) and case–control (P= 0.0115) analysis of matched
cases. Interestingly, the RET+ 9.7 T allele frequency is significantly different between …
Abstract
Individuals with Down syndrome (DS) display a 40‐fold greater risk of Hirschsprung disease (HSCR) than the general population of newborns implicating chromosome 21 in HSCR etiology. Here we demonstrate that the RET enhancer polymorphism RET+9.7 (rs2435357:C>T) at chromosome 10q11.2 is associated with HSCR in DS individuals both by transmission disequilibrium (P=0.0015) and case–control (P=0.0115) analysis of matched cases. Interestingly, the RET+9.7 T allele frequency is significantly different between individuals with DS alone (0.26±0.04), HSCR alone (0.61±0.04), and those with HSCR and DS (0.41±0.04), demonstrating an association and interaction between RET and chromosome 21 gene dosage. This is the first report of a genetic interaction between a common functional variant (rs2435357) and a not infrequent copy number error (chromosome 21 dosage) in two human developmental disorders. Hum Mutat 30:1–5, 2009. © 2009 Wiley‐Liss, Inc.
Wiley Online Library